This announcement is a separate document:
康弘药业：2024年半年度报告摘要
Chengdu Kanghong Pharmaceutical Group: Summary of Half-Year Report in 2024.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Latest
07:37
Banks and Securities: The A-share market may experience a volatile upward spiral.
CGS-1.18%
07:35
China Galaxy Securities' Zhang Jun: In the future, China's economic growth needs to rely more on substantial breakthroughs in the Technology sector.
CGS-1.18%
07:34
Trump stated that he does not wish to build any wind farms during his presidential term.
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.